ÂÜÀòÂÒÂ×

P. David Mozley currently serves as Chief Medical Officer at both Lutroo Imaging and Norroy Biosciences North America since January 2024. Previously, P. David Mozley held the position of Chief Medical Officer at Radiopharm Theranostics, Inc. from July 2021 to January 2024, and served as a Professor at Weill Cornell Medicine from August 2017 to July 2021. Additional experience includes roles as Vice President at Endocyte and Advisor at Lucerno. Significant past responsibilities involved managing clinical operations at Weill Cornell Medical College, co-chairing the Computed Tomography Technical & Modality Committees for the Quantitative Imaging Biomarker Alliance, and holding a senior director position at Merck & Co, Inc. Educational qualifications include a Bachelor of Science in Physical Chemistry from William & Mary, an M.D. from The Brody School of Medicine at East Carolina University, along with multiple degrees from the University of Pennsylvania and an internship in Medicine at Thomas Jefferson University.